Abstract

Brain region- and cell-specific transcriptomic and epigenomic features are associated with heritability for neuropsychiatric traits, but a systematic view, considering cortical and subcortical regions, is lacking. Here, we provide an atlas of chromatin accessibility and gene expression profiles in neuronal and non-neuronal nuclei across 25 distinct human cortical and subcortical brain regions from 6 neurotypical controls. We identified extensive gene expression and chromatin accessibility differences across brain regions, including variation in alternative promoter-isoform usage and enhancer-promoter interactions. Genes with distinct promoter-isoform usage across brain regions were strongly enriched for neuropsychiatric disease risk variants. Moreover, we built enhancer-promoter interactions at promoter-isoform resolution across different brain regions and highlighted the contribution of brain region-specific and promoter-isoform-specific regulation to neuropsychiatric disorders. Including promoter-isoform resolution uncovers additional distal elements implicated in the heritability of diseases, thereby increasing the power to fine-map risk genes. Our results provide a valuable resource for studying molecular regulation across multiple regions of the human brain and underscore the importance of considering isoform information in gene regulation.

Brain gene regulation is key for neuropsychiatric disorders. Here, the authors show that profiling gene expression and chromatin states in 25 brain regions enables enhancer-promoter mapping at isoform resolution, improving genetic fine-mapping.

Details

Title
A multi-regional human brain atlas of chromatin accessibility and gene expression facilitates promoter-isoform resolution genetic fine-mapping
Author
Dong, Pengfei 1   VIAFID ORCID Logo  ; Song, Liting 1 ; Bendl, Jaroslav 1   VIAFID ORCID Logo  ; Misir, Ruth 2 ; Shao, Zhiping 1 ; Edelstien, Jonathan 2 ; Davis, David A. 3 ; Haroutunian, Vahram 4   VIAFID ORCID Logo  ; Scott, William K. 5   VIAFID ORCID Logo  ; Acker, Susanne 6 ; Lawless, Nathan 6   VIAFID ORCID Logo  ; Hoffman, Gabriel E. 7   VIAFID ORCID Logo  ; Fullard, John F. 1   VIAFID ORCID Logo  ; Roussos, Panos 8   VIAFID ORCID Logo 

 Icahn School of Medicine at Mount Sinai, Center for Disease Neurogenomics, New York, USA (GRID:grid.59734.3c) (ISNI:0000 0001 0670 2351); Icahn School of Medicine at Mount Sinai, Friedman Brain Institute, New York, USA (GRID:grid.59734.3c) (ISNI:0000 0001 0670 2351); Icahn School of Medicine at Mount Sinai, Department of Psychiatry, New York, USA (GRID:grid.59734.3c) (ISNI:0000 0001 0670 2351); Icahn School of Medicine at Mount Sinai, Department of Genetics and Genomic Science, New York, USA (GRID:grid.59734.3c) (ISNI:0000 0001 0670 2351) 
 Icahn School of Medicine at Mount Sinai, Friedman Brain Institute, New York, USA (GRID:grid.59734.3c) (ISNI:0000 0001 0670 2351); Icahn School of Medicine at Mount Sinai, Department of Psychiatry, New York, USA (GRID:grid.59734.3c) (ISNI:0000 0001 0670 2351); Icahn School of Medicine at Mount Sinai, Department of Genetics and Genomic Science, New York, USA (GRID:grid.59734.3c) (ISNI:0000 0001 0670 2351) 
 University of Miami, Brain Endowment Bank, Department of Neurology, Miller School of Medicine, Miami, USA (GRID:grid.26790.3a) (ISNI:0000 0004 1936 8606) 
 Icahn School of Medicine at Mount Sinai, Friedman Brain Institute, New York, USA (GRID:grid.59734.3c) (ISNI:0000 0001 0670 2351); Icahn School of Medicine at Mount Sinai, Department of Psychiatry, New York, USA (GRID:grid.59734.3c) (ISNI:0000 0001 0670 2351); Icahn School of Medicine at Mount Sinai, Department of Neuroscience, New York, USA (GRID:grid.59734.3c) (ISNI:0000 0001 0670 2351); James J. Peters VA Medical Center, Mental Illness Research Education and Clinical Center (MIRECC), Bronx, USA (GRID:grid.274295.f) (ISNI:0000 0004 0420 1184) 
 University of Miami, Brain Endowment Bank, Department of Neurology, Miller School of Medicine, Miami, USA (GRID:grid.26790.3a) (ISNI:0000 0004 1936 8606); University of Miami, John P. Hussman Institute for Human Genomics and Dr. John T. Macdonald Foundation Department of Human Genetics, Miller School of Medicine, Miami, USA (GRID:grid.26790.3a) (ISNI:0000 0004 1936 8606) 
 Boehringer Ingelheim Pharma GmbH and Co. KG, Global Computational Biology and Digital Sciences, Biberach, Germany (GRID:grid.420061.1) (ISNI:0000 0001 2171 7500) 
 Icahn School of Medicine at Mount Sinai, Center for Disease Neurogenomics, New York, USA (GRID:grid.59734.3c) (ISNI:0000 0001 0670 2351); Icahn School of Medicine at Mount Sinai, Department of Psychiatry, New York, USA (GRID:grid.59734.3c) (ISNI:0000 0001 0670 2351); Icahn School of Medicine at Mount Sinai, Department of Genetics and Genomic Science, New York, USA (GRID:grid.59734.3c) (ISNI:0000 0001 0670 2351); James J. Peters VA Medical Center, Mental Illness Research Education and Clinical Center (MIRECC), Bronx, USA (GRID:grid.274295.f) (ISNI:0000 0004 0420 1184); James J. Peters VA Medical Center, Center for Precision Medicine and Translational Therapeutics, Bronx, USA (GRID:grid.274295.f) (ISNI:0000 0004 0420 1184) 
 Icahn School of Medicine at Mount Sinai, Center for Disease Neurogenomics, New York, USA (GRID:grid.59734.3c) (ISNI:0000 0001 0670 2351); Icahn School of Medicine at Mount Sinai, Friedman Brain Institute, New York, USA (GRID:grid.59734.3c) (ISNI:0000 0001 0670 2351); Icahn School of Medicine at Mount Sinai, Department of Psychiatry, New York, USA (GRID:grid.59734.3c) (ISNI:0000 0001 0670 2351); Icahn School of Medicine at Mount Sinai, Department of Genetics and Genomic Science, New York, USA (GRID:grid.59734.3c) (ISNI:0000 0001 0670 2351); James J. Peters VA Medical Center, Mental Illness Research Education and Clinical Center (MIRECC), Bronx, USA (GRID:grid.274295.f) (ISNI:0000 0004 0420 1184); James J. Peters VA Medical Center, Center for Precision Medicine and Translational Therapeutics, Bronx, USA (GRID:grid.274295.f) (ISNI:0000 0004 0420 1184) 
Pages
10113
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3132019600
Copyright
© This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.